{"transactions":[{"id":1474330,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89757,"kind":"person","name":"Manting Erik","position":1,"cik":"0001856180","reported_name":"Manting Erik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:16:30.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":1.2,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-24-072825","document":"tm2417512-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465924072825/tm2417512-3_4seq1.xml","form_type":"4"}},{"id":1883942,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89757,"kind":"person","name":"Manting Erik","position":1,"cik":"0001856180","reported_name":"Manting Erik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-20T00:09:27.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time."}],"balance_after":45000,"derivative":{"exercise_price":0.2834,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-23-062816","document":"tm2316383-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465923062816/tm2316383-6_4seq1.xml","form_type":"4"}},{"id":1897764,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89757,"kind":"person","name":"Manting Erik","position":1,"cik":"0001856180","reported_name":"Manting Erik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-10T22:13:03.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 10, 2024 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":9500,"derivative":{"exercise_price":0.2985,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-058582","document":"tm2315294-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465923058582/tm2315294-3_4seq1.xml","form_type":"4"}},{"id":2223675,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89757,"kind":"person","name":"Manting Erik","position":1,"cik":"0001856180","reported_name":"Manting Erik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T00:24:39.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":9500,"derivative":{"exercise_price":1.24,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-22-073634","document":"tm2219203-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465922073634/tm2219203-1_4seq1.xml","form_type":"4"}}]}